Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 3.000% 6/0
-
Market price (% of par)
-
84.93%
-
Total 13F principal
-
$130,401,740
-
Principal change
-
-$162,000
-
Total reported market value
-
$112,027,000
-
Number of holders
-
22
-
Value change
-
+$203,105
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 as of Q2 2016
As of 30 Jun 2016,
ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 was held by
22 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$130,401,740
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT CO, WOLVERINE ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, SILVERBACK ASSET MANAGEMENT LLC, UBS OCONNOR LLC, BARCLAYS PLC, ADVENT CAPITAL MANAGEMENT /DE/, CSS LLC/IL, MACKAY SHIELDS LLC, and QVT Financial LP.
This page lists
22
institutional bondholders reporting positions
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.